KLP Kapitalforvaltning AS Acquires Shares of 27,800 Astera Labs, Inc. $ALAB

Key Points

• KLP Kapitalforvaltning AS acquired 27,800 shares of Astera Labs, Inc., valued at approximately $2,514,000, in the second quarter.
• Astera Labs reported earnings of $0.44 per share for the latest quarter, exceeding analysts' expectations of $0.33, with revenues up 149.5% compared to the previous year.
• Institutional investors own 60.47% of Astera Labs' stock, with significant increases in holdings from companies like Vanguard Group Inc. and Alliancebernstein L.P. in the first quarter.

KLP Kapitalforvaltning AS acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 27,800 shares of the company's stock, valued at approximately $2,514,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. grew its holdings in Astera Labs by 0.9% during the first quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company's stock valued at $554,780,000 after purchasing an additional 85,846 shares during the period. Alliancebernstein L.P. boosted its holdings in shares of Astera Labs by 114.2% in the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company's stock worth $501,289,000 after acquiring an additional 4,478,741 shares during the period. Atreides Management LP boosted its holdings in shares of Astera Labs by 153.3% in the first quarter. Atreides Management LP now owns 4,652,264 shares of the company's stock worth $277,601,000 after acquiring an additional 2,815,614 shares during the period. Fred Alger Management LLC boosted its holdings in shares of Astera Labs by 13.0% in the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock worth $93,087,000 after acquiring an additional 179,638 shares during the period. Finally, FengHe Fund Management Pte. Ltd. bought a new position in shares of Astera Labs in the second quarter worth $106,772,000. 60.47% of the stock is owned by institutional investors.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $206.21 on Friday. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90. The company has a market cap of $34.28 billion, a PE ratio of 368.23, a P/E/G ratio of 5.14 and a beta of 1.43. The stock's 50-day moving average is $198.72 and its 200 day moving average is $124.57.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The company had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. During the same quarter in the previous year, the business earned $0.13 EPS. Astera Labs's revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Jack R. Lazar sold 22,500 shares of Astera Labs stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $178.42, for a total transaction of $4,014,450.00. Following the sale, the director directly owned 97,351 shares of the company's stock, valued at approximately $17,369,365.42. The trade was a 18.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the sale, the director directly owned 385,863 shares in the company, valued at approximately $66,858,482.01. The trade was a 32.17% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 1,308,772 shares of company stock worth $214,482,678. Insiders own 12.50% of the company's stock.

Analysts Set New Price Targets

Several research firms recently issued reports on ALAB. Morgan Stanley lifted their price objective on Astera Labs from $155.00 to $200.00 and gave the company an "overweight" rating in a research note on Friday, August 29th. Needham & Company LLC raised their price target on Astera Labs from $100.00 to $170.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Jefferies Financial Group raised their price target on Astera Labs from $95.00 to $130.00 and gave the company a "buy" rating in a research report on Tuesday, July 22nd. Bank of America began coverage on Astera Labs in a research report on Friday, October 3rd. They set a "neutral" rating and a $230.00 price target on the stock. Finally, Stifel Nicolaus set a $145.00 price target on Astera Labs and gave the company a "buy" rating in a research report on Monday, August 4th. Fifteen equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to MarketBeat, Astera Labs presently has a consensus rating of "Moderate Buy" and an average target price of $159.83.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.